Presence of the HLA-DR7 allele in transplant patients has been proposed as a risk factor for human cytomegalovirus (HCMV)-associated complications, however, the precise mechanism of this increased risk remains unresolved. Here we show that HLA-DR7-restricted HCMV-specific CD4+ CTLs can display an unusual dual specificity towards a gylcoprotein-B epitope and the alloantigen HLA-DR4. On the other hand, no HLA-DR4-specific alloreactivity was observed when the gB-specific CTLs were generated from virus carriers expressing both HLA- evading an area of the epitope that mimics a structure presented on HLA-DR4.
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These data illustrate a possible mechanism for the clinical association between HCMV and graft-versus-host disease. . In the present study we show that HCMV-specific CD4+ T cells can display an unusual cross-reactivity towards alloantigens and may therefore have the potential to contribute towards transplant rejection or graft-versus-host disease. 
Material and Methods

Establishment and Maintenance of Cell Lines
Epstein Barr virus-transformed lymphoblastoid cell lines (LCLs) transformed with B95.8 virus isolate were used in this study. In addition, murine L cell line expressing HLA-DR7 (referred to as DAP-DR7) were also used in this study.
Peptide Synthesis
Overlapping peptides from HCMV glycoproteins gB and gH were synthesized using the Merrifield solid phase method 10 and purchased from Chiron Mimotopes (Melbourne, Australia).
Generation of HCMV-specific CTL clones
HCMV-specific CTL clones were generated as described previously 11; 12 .
Limiting Dilution CTL Microcultures and Cytotoxicity Assay
PBMC were distributed in graded numbers (two fold dilutions) from 6.25 x 10 3 to 5
x 10 4 cells per well in round-bottomed microtiter plates. Approximately 5 x 10 4 -irradiated (2,000 rads) peptide-sensitized (1µg/ml) auologous PBMC were added to give a total volume of 100 µl. Twenty-four replicates were used at each concentration in each experiment. On day 10, each CTL microculture was split into two replicates and used as effectors in a standard 5 h 51 Cr-release assay 11 against autologous DAP DR7 cells pre-coated with gB peptide or HLA-DR4-positive LCLs.
Statistical Analysis
The difference in the level of lysis from limiting dilution CTL microcultures were analyzed by student T-test. The CTL recognition of alloantigen HLA-DR4 by gB-specific CTL clones raised the possibility that individuals who are both HLA-DR7+ and DR4+ may not respond to the gB epitope because of self-tolerance. To test this hypothesis, a series of CD4+ CTL clones were isolated from an HLA-DR4+/DR7+ individual and their reactivity tested against HCMV peptide-sensitized HLA-DR7-positive and HLA-DR4-positive targets (Fig 1, panel B) . As shown in Fig. 1, panel B , the gBspecific CTL clone could recognize the epitope presented in association with the HLA-DR7 molecule, but did not lyse either peptide-sensitized or unsensitized HLA-DR4-positive target cells. These observations suggest that the T cell clonotype(s) that usually dominates the memory response for this gB epitope is probably inactivated by mechanisms of self tolerance in HLA-DR4+ individuals.
To further confirm this observation, multiple CTL microcultures were raised by limiting dilution from two HLA-DR7+ individuals after in vitro stimulation with the gB epitope (Fig.1, panel C) . Donor 1 was HLA-DR7+/DR4-, while donor 2 was HLA-DR7+/DR4+. Each microculture was assayed separately for CTL activity against HLA-DR7+ target cells (DAP DR7) with and without the peptide DYSNTHSTRYV, as well as HLA-DR4+ LCLs (no peptide). All CTL microcultures from Donor 1 (HLA-DR7+, DR4-) that recognized the gB peptide in association with HLA-DR7 cross-reacted with the alloantigen HLA-DR4 (Fig. 1, panel C) . In contrast, the microcultures from Donor 2 (HLA-DR7+ DR4+) showed reactivity towards the gB eptiope in association with HLA-DR7, yet failed to recognize HLA-DR4+ targets. These observations were consistent with the data obtained with individual CTL clones (Fig. 1, panel A & B) and demonstrate the clonal inactivation The data presented here are consistent with previous studies that suggest memory T cells play an important role in human alloresponses [15] [16] [17] . It is now well established that healthy seropositive individuals generally display very high 
